Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Share-based Compensation (2018 - 2025)

AVITA Medical filings provide 8 years of Share-based Compensation readings, the most recent being $1.4 million for Q4 2025.

  • On a quarterly basis, Share-based Compensation fell 50.93% to $1.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $9.5 million, a 29.47% decrease, with the full-year FY2025 number at $9.5 million, down 29.47% from a year prior.
  • Share-based Compensation hit $1.4 million in Q4 2025 for AVITA Medical, down from $2.8 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $4.1 million in Q3 2024 to a low of $1.1 million in Q2 2023.
  • Median Share-based Compensation over the past 5 years was $2.5 million (2023), compared with a mean of $2.3 million.
  • Biggest five-year swings in Share-based Compensation: skyrocketed 252.32% in 2024 and later tumbled 50.93% in 2025.
  • AVITA Medical's Share-based Compensation stood at $1.8 million in 2021, then tumbled by 33.98% to $1.2 million in 2022, then surged by 78.54% to $2.2 million in 2023, then grew by 28.88% to $2.8 million in 2024, then tumbled by 50.93% to $1.4 million in 2025.
  • The last three reported values for Share-based Compensation were $1.4 million (Q4 2025), $2.8 million (Q3 2025), and $2.7 million (Q2 2025) per Business Quant data.